Banzhou Pan

902 total citations
22 papers, 713 citations indexed

About

Banzhou Pan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Banzhou Pan has authored 22 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Banzhou Pan's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Banzhou Pan is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Banzhou Pan collaborates with scholars based in China and Taiwan. Banzhou Pan's co-authors include Longbang Chen, Haizhu Song, Jiayuan Huang, Dongqin Chen, Rui Wang, Yitian Chen, Wei De, Jun Yi, Bing Feng and Yichen Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Banzhou Pan

21 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Banzhou Pan China 14 476 414 199 133 89 22 713
I‐Hsiao Chung Taiwan 16 446 0.9× 373 0.9× 63 0.3× 75 0.6× 60 0.7× 18 644
Tianwei Xu China 10 480 1.0× 399 1.0× 55 0.3× 72 0.5× 58 0.7× 16 597
Katharine Grimmer United States 6 339 0.7× 250 0.6× 192 1.0× 83 0.6× 50 0.6× 10 595
Anagha Inguva Sheth United States 8 438 0.9× 152 0.4× 95 0.5× 95 0.7× 36 0.4× 16 616
Zhi Yan China 13 319 0.7× 242 0.6× 102 0.5× 80 0.6× 50 0.6× 29 588
Tian‐En Li China 8 250 0.5× 173 0.4× 70 0.4× 116 0.9× 71 0.8× 9 451
Wenbing Sun China 14 226 0.5× 189 0.5× 126 0.6× 121 0.9× 70 0.8× 25 602
Cheng-Chung Wu Taiwan 14 259 0.5× 115 0.3× 140 0.7× 146 1.1× 123 1.4× 18 641
Hisateru Komatsu Japan 18 572 1.2× 514 1.2× 116 0.6× 183 1.4× 105 1.2× 47 851

Countries citing papers authored by Banzhou Pan

Since Specialization
Citations

This map shows the geographic impact of Banzhou Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banzhou Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banzhou Pan more than expected).

Fields of papers citing papers by Banzhou Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banzhou Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banzhou Pan. The network helps show where Banzhou Pan may publish in the future.

Co-authorship network of co-authors of Banzhou Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Banzhou Pan. A scholar is included among the top collaborators of Banzhou Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banzhou Pan. Banzhou Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wu, Yuan, Xuefeng Zhou, Weiqing Zhao, et al.. (2023). Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial. Investigational New Drugs. 41(6). 825–833. 2 indexed citations
4.
Pan, Banzhou, Jiayuan Huang, Bo Shen, et al.. (2023). CircRNA G6PC3 promotes lung adenocarcinoma progression through enhancing HMGB1/Beclin 1 complex to induce autophagy. Biomedical Signal Processing and Control. 90. 105758–105758. 1 indexed citations
5.
Pan, Banzhou, Jiayuan Huang, Yuxin Du, et al.. (2023). PDE4D/cAMP/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytes. Cancer Letters. 565. 216224–216224. 13 indexed citations
6.
Huang, Xing, Shaorong Yu, Bo Shen, et al.. (2022). A Prognostic Risk Model of a Novel Oxidative Stress‐Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2022(1). 2262014–2262014. 6 indexed citations
7.
8.
Huang, Jiayuan, et al.. (2020). LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death and Disease. 11(7). 525–525. 46 indexed citations
9.
Chen, Jing, Xiang Liu, Yichen Xu, et al.. (2019). TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells. Molecular Therapy — Nucleic Acids. 14. 567–582. 53 indexed citations
10.
Yi, Jun, et al.. (2015). Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. Tumor Biology. 37(6). 7139–7148. 13 indexed citations
11.
Pan, Banzhou, Bing Feng, Yitian Chen, et al.. (2015). MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma. Oncotarget. 6(32). 32805–32820. 63 indexed citations
12.
Chen, Dongqin, Jiayuan Huang, Kai Zhang, et al.. (2014). MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc. European Journal of Cancer. 50(17). 3050–3067. 71 indexed citations
13.
Pan, Banzhou, Dongqin Chen, Jiayuan Huang, et al.. (2014). HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Molecular Cancer. 13(1). 165–165. 122 indexed citations
14.
Chen, Dongqin, Jiayuan Huang, Bing Feng, et al.. (2014). Histone Deacetylase 1/Sp1/MicroRNA-200b Signaling Accounts for Maintenance of Cancer Stem-Like Cells in Human Lung Adenocarcinoma. PLoS ONE. 9(10). e109578–e109578. 23 indexed citations
15.
Chen, Dongqin, Banzhou Pan, Jiayuan Huang, et al.. (2014). HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells. Oncotarget. 5(10). 3333–3349. 46 indexed citations
16.
Pan, Banzhou, Yitian Chen, Haizhu Song, et al.. (2014). Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget. 6(1). 317–331. 89 indexed citations
17.
Wang, Rui, Dongqin Chen, Jiayuan Huang, et al.. (2014). Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling. Oncotarget. 5(15). 6113–6129. 35 indexed citations
18.
19.
Pan, Banzhou, Jun Yi, & Haizhu Song. (2013). MicroRNA-Mediated Autophagic Signaling Networks and Cancer Chemoresistance. Cancer Biotherapy and Radiopharmaceuticals. 28(8). 573–578. 22 indexed citations
20.
Zheng, Yun, Rui Wang, Haizhu Song, et al.. (2013). Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway. The International Journal of Biochemistry & Cell Biology. 45(11). 2369–2378. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I‐Hsiao Chung Breakdown of academic impact, for papers by Tianwei Xu Breakdown of academic impact, for papers by Katharine Grimmer Breakdown of academic impact, for papers by Anagha Inguva Sheth Breakdown of academic impact, for papers by Zhi Yan Breakdown of academic impact, for papers by Tian‐En Li Breakdown of academic impact, for papers by Wenbing Sun Breakdown of academic impact, for papers by Cheng-Chung Wu Breakdown of academic impact, for papers by Hisateru Komatsu
Rankless by CCL
2026